Circulating epithelial cells as potential biomarkers for detection of recurrence in patients of papillary thyroid carcinoma with positive serum anti-thyroglobulin antibody.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Clinica chimica acta; international journal of clinical chemistry

• Publication date

  2018-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.cca.2017.12.011PMID 29229463
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Circulating epithelial cell counts for monitoring the therapeutic outcome of patients with papillary thyroid carcinoma

  2017cited by this paper
• Circulating tumor cells: clinical validity and utility

  2017cited by this paper
• Circulating epithelial cell enumeration facilitates the identification and follow-up of a patient with early stage papillary thyroid microcarcinoma: A case report.

  2016cited by this paper
• Detection and Prognostic Significance of Circulating Tumor Cells in Patients With Metastatic Thyroid Cancer.

  2016cited by this paper
• High‐resolution imaging for the detection and characterisation of circulating tumour cells from patients with oesophageal, hepatocellular, thyroid and ovarian cancers

  2015cited by this paper
• Cytokeratin 20 improves the detection of circulating tumor cells in patients with colorectal cancer.

  2015cited by this paper
• Long-Term Follow-Up of the Therapeutic Outcomes for Papillary Thyroid Carcinoma With Distant Metastasis

  2015cited by this paper
• Combined analysis of circulating epithelial cells and serum thyroglobulin for distinguishing disease status of the patients with papillary thyroid carcinoma

  2015cited by this paper
• Determining tissue origin of circulating epithelial cells (CEC) in patients with differentiated thyroid cancer by real-time PCR using thyroid mRNA probes.

  2015cited by this paper
• Prognostic value of circulating tumor cells with podoplanin expression in patients with locally advanced or metastatic head and neck squamous cell carcinoma

  2015cited by this paper
• Sequential Changes of Serum Antithyroglobulin Antibody Levels Are a Good Predictor of Disease Activity in Thyroglobulin-Negative Patients with Papillary Thyroid Carcinoma

  2014cited by this paper
• Approach to follow-up of the patient with differentiated thyroid cancer and positive anti-thyroglobulin antibodies.

  2013cited by this paper
• Circulating tumor cells: liquid biopsy of cancer.

  2013cited by this paper
• Implications of Thyroglobulin Antibody Positivity in Patients with Differentiated Thyroid Cancer: A Clinical Position Statement

  2013cited by this paper
• A negative selection system PowerMag for effective leukocyte depletion and enhanced detection of EpCAM positive and negative circulating tumor cells.

  2013cited by this paper
• Thyroid function and prevalence of anti-thyroperoxidase (TPO) and anti-thyroglobulin (Tg) antibodies in outpatients hospital setting in an area with sufficient iodine intake: influences of age and sex.

  2013cited by this paper
• New developments in the diagnosis and treatment of thyroid cancer

  2013cited by this paper
• Estimation of True Serum Thyroglobulin Concentration Using Simultaneous Measurement of Serum Antithyroglobulin Antibody

  2013cited by this paper
• Circulating BRAFV600E in the diagnosis and follow-up of differentiated papillary thyroid carcinoma.

  2013cited by this paper
• Epithelial cell adhesion molecule expression (CD326) in cancer: a short review.

  2012cited by this paper
• Circulating microRNA profiles as potential biomarkers for diagnosis of papillary thyroid carcinoma.

  2012cited by this paper
• Circulating epithelial cells in patients with thyroid carcinoma

  2012cited by this paper
• Characterization of metastatic breast cancer patients with nondetectable circulating tumor cells

  2011cited by this paper
• The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM

  2010cited by this paper
• Circulating tumor cell assays for the prognosis of prostate and colon cancers.

  2009cited by this paper
• 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer

  2009cited by this paper
• Change of serum antithyroglobulin antibody levels is useful for prediction of clinical recurrence in thyroglobulin-negative patients with differentiated thyroid carcinoma.

  2008cited by this paper
• Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients

  2008cited by this paper
• EpCAM (CD326) finding its role in cancer

  2007cited by this paper
• Development and clinical impact of thyroglobulin antibodies in patients with differentiated thyroid carcinoma during the first 3 years after thyroidectomy.

  2005cited by this paper
• Circulating tumor cells detected by reverse transcription-polymerase chain reaction for carcinoembryonic antigen mRNA: distinguishing follicular thyroid carcinoma from adenoma.

  2005cited by this paper
• Minireview: structural and functional evolution of the thyrotropin receptor.

  2004cited by this paper
• Anticuerpos anti-tiroglobulina en el seguimiento de pacientes con cáncer diferenciado de tiroides: ¿Marcadores de enfermedad residual o recidivante?

  2002cited by this paper
• [Anti thyroglobulin antibodies in the follow up of patients with differentiated thyroid cancer: residual or relapsing disease markers?].

  2002cited by this paper
• Thyroid-stimulating hormone and thyroid-stimulating hormone receptor structure-function relationships.

  2002cited by this paper
• Ep-CAM: a human epithelial antigen is a homophilic cell-cell adhesion molecule

  1994cited by this paper

• Development of PowerMag System II for Isolation of Circulating Tumor Cells with Improved Purity

  2025cites this paper
• Single-cell RNA-seq reveals MIF-(CD74 + CXCR4) dependent inhibition of macrophages in metastatic papillary thyroid carcinoma.

  2023cites this paper
• Opportunities and Challenges of Liquid Biopsy in Thyroid Cancer

  2021cites this paper
• Sequential Circulating Tumor Cell Counts in Patients with Locally Advanced or Metastatic Hepatocellular Carcinoma: Monitoring the Treatment Response

  2020cites this paper
• The role of anti-thyroglobulin antibody in treatment and follow up of differentiated thyroid cancer

  2020cites this paper
• Liquid biopsy in thyroid cancer: from circulating biomarkers to a new prospective of tumor monitoring and therapy.

  2020cites this paper
• Potential values of circulating tumor cell for detection of recurrence in patients of thyroid cancer: a diagnostic meta-analysis

  2020cites this paper
• Liquid Biopsies in Endocrine Neoplasia—A Systematic Review

  2019cites this paper
• Liquid Biopsy in Patients with Thyroid Carcinoma

  2019cites this paper
• Circulating Epithelial Cell Characterization and Correlation with Remission and Survival in Patients with Thyroid Cancer

  2018influential citation
• 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer

  2009cites this paper